Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma

Chen, 2020, Recent progress in treatment of hepatocellular carcinoma, Am J Cancer Res, 10, 2993 Feng, 2019, Current cancer situation in China: good or bad news from the 2018 global cancer statistics?, Cancer Commun, 39, 22, 10.1186/s40880-019-0368-6 Grandhi, 2016, Hepatocellular carcinoma: from diagnosis to treatment, Surg Oncol, 25, 74, 10.1016/j.suronc.2016.03.002 Covey, 2017, Liver-directed therapy for hepatocellular carcinoma: an overview of techniques, outcomes, and posttreatment imaging findings, AJR Am J Roentgenol, 209, 67, 10.2214/AJR.17.17799 Zhang, 2018, A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE, Cancer Biol Ther, 19, 475, 10.1080/15384047.2018.1433501 Zhang, 2017, Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis, Oncotarget, 8, 29416, 10.18632/oncotarget.15075 Pinato, 2018, Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma, BMC Cancer, 18, 211, 10.1186/s12885-018-4120-4 Petrillo, 2018, Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments, Future Oncol, 14, 2957, 10.2217/fon-2017-0739 Yang, 2018, Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma, Cancer Med, 7, 4570, 10.1002/cam4.1664 Li, 2013, Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial, J Clin Oncol, 31, 3219, 10.1200/JCO.2013.48.8585 Li, 2017, Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China, Oncotarget, 8, 64471, 10.18632/oncotarget.16293 Hu, 2014, Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer, BMC Cancer, 14, 820, 10.1186/1471-2407-14-820 Lu, 2017, Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: a single-center randomized controlled trial, Cancer Biol Ther, 18, 433, 10.1080/15384047.2017.1323589 Yu, 2019, Apatinib in the treatment of advanced non-small-cell lung cancer: a meta-analysis, Math Biosci Eng, 16, 7659, 10.3934/mbe.2019383 Chen, 2018, Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma, BMC Cancer, 18, 1131, 10.1186/s12885-018-5081-3 Yang, 2019, The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study, Cancer Biol Ther, 20, 321, 10.1080/15384047.2018.1529099 Gu, 2020, Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma, Ann Transl Med, 8, 1677, 10.21037/atm-20-7244 Lencioni, 2010, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Semin Liver Dis, 30, 52, 10.1055/s-0030-1247132 Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X Du, 2017, The roles of vasohibin and its family members: beyond angiogenesis modulators, Cancer Biol Ther, 18, 827, 10.1080/15384047.2017.1373217 Dong, 2018, Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15, Cancer Med, 7, 820, 10.1002/cam4.1330 Qiu, 2019, Efficacy of apatinib in transcatheter arterial chemoembolization (TACE) refractory intermediate and advanced-stage hepatocellular carcinoma A propensity score matching analysis, Cancer Manag Res, 11, 9321, 10.2147/CMAR.S223271 Li, 2020, Efficacy and safety of apatinib monotherapy in elderly patients with advanced metastatic non-small cell lung cancer, Indian J Cancer, 57, 13, 10.4103/ijc.IJC_614_18